Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Seminars in Arthritis and Rheumatism
|
July 27, 2010
Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus
Anna Carmela P Sagcal-Gironella, Tsuyoshi Fukuda, Kristina Wiers, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 13, 2025
LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults
Tsuyoshi Fukuda, Brian R Thompson, Bram Brouwers, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2023
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy
Kana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, et al.
Clinical Transplantation
|
March 26, 2017
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy
Tayyab S Diwan, Alicia B Lichvar, Abbie D Leino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Sonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Bone Marrow Transplantation
|
April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study
Pooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation
Pooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation
|
September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategy
Danielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Pediatric Transplantation
|
September 5, 2017
Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs
Charles D Varnell, Tsuyoshi Fukuda, Cassie L Kirby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Seminars in Arthritis and Rheumatism
|
July 27, 2010
Pharmacokinetics and pharmacodynamics of mycophenolic acid and their relation to response to therapy of childhood-onset systemic lupus erythematosus
Anna Carmela P Sagcal-Gironella, Tsuyoshi Fukuda, Kristina Wiers, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 13, 2025
LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults
Tsuyoshi Fukuda, Brian R Thompson, Bram Brouwers, et al.
Clinical Pharmacology and Therapeutics
|
June 14, 2023
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy
Kana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, et al.
Clinical Transplantation
|
March 26, 2017
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy
Tayyab S Diwan, Alicia B Lichvar, Abbie D Leino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Sonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Bone Marrow Transplantation
|
April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study
Pooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation
Pooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation
|
September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategy
Danielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Pediatric Transplantation
|
September 5, 2017
Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs
Charles D Varnell, Tsuyoshi Fukuda, Cassie L Kirby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Page
of 12